Alpha-1 Foundation DNA and Tissue Bank
Part of paid clinical trials in Gainesville, Florida.
- Sponsor
- University of Florida
- Study ID
- NCT00884455
- Status
- Enrolling By Invitation
Conditions
- Alpha 1 Antitrypsin Deficiency
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Years - 100 Years
- Healthy Volunteers
- Accepted
Study Details
This is a long-term follow-up banking protocol that collects medical information and tissue (blood, liver and lung) samples for future research; use of data and samples for research purposes is overseen by the Tissue Bank Advisory Committee; the purpose of the Bank is to further research on alpha-1 antitrypsin deficiency.
Key Dates
- Start date
- Dec 31, 2002
- Status verified
- Aug 2025
- Primary completion
- Jun 10, 2032
- Completion
- Jun 10, 2033
Study Design
- Enrollment
- 5,000 participants (estimated)
Primary Outcome Measure
Data and tissue samples [ Time Frame: The total number of tissue samples received and used for research are tracked annually. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Florida | Gainesville | Florida | 32610 | - |
Find similar trials in Gainesville, FL
By research site
Related Studies
- A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)PHASE3 · Recruiting · Grifols Therapeutics LLC · Birmingham, Alabama